Skip to main content
OpenTrials
Completed

NCT Number: NCT02885116

Effect of Nasal Highflow on Right Heart Function

In this study effect of NHF on pulmonary thermodynamic parameters will studied.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Respiratory Medicine

Leipzig, Saxony, 04103, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • stable disease
  • hypoxemic respiratory disorder

Exclusion criteria

  • decompensation
  • acute illness

Treatment and study plan

Nasal high flow (NHF) supplementation

Device

use of NHF for 20 min/ 35 l/min, at the end of this period right heart catheterization

oxygen supplementation

Device

hypoxemic patients will use their normal oxygen supplementation durch right heart catheterization

Primary outcomes

  1. changes in mean pulmonary pressure (PAPm)

    Time frame: 20 min

    measured in mmHg

Secondary outcomes

  1. changes in wedge pressure (PC)

    Time frame: 20 min

    mmHg

  2. changes in cardiac index (CI)

    Time frame: 20 min

    l/min/qm

Sponsors and collaborators

Lead sponsor

University of Leipzig

Other

Registry information

Official study title

Hemodynamic Effects of Nasal Highflow on Patients With Chronic Respiratory Insufficiency and Pulmonary Hypertension

Acronym: HÄMOFLOW

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Aug 31, 2016
Registry last updated
Jun 26, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.